CurveBeam AI Limited (ASX:CVB)

Market Cap	24.36M -34.3%
Revenue (ttm)	12.15M +53.7%
Net Income	-16.17M
EPS	-0.04
Shares Out	477.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	165,178
Open	0.0480
Previous Close	0.0490
Day's Range	0.0480 - 0.0510
52-Week Range	0.0450 - 0.1750
Beta	1.95
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2026

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Sof...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 50
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CVB

Financial Performance

In fiscal year 2025, CurveBeam AI's revenue was 12.10 million, an increase of 85.33% compared to the previous year's 6.53 million. Losses were -16.84 million, -27.09% less than in 2024.